|
|
Volumn 26, Issue 6, 2008, Pages 591-592
|
|
HIV vaccine developers battle on, despite high-profile failures
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GAG PROTEIN;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOLOGICAL ADJUVANT;
NEF PROTEIN;
PLASMID DNA;
POL PROTEIN;
REV PROTEIN;
TRANSACTIVATOR PROTEIN;
VIRUS DNA;
VIRUS ENVELOPE PROTEIN;
VIRUS PROTEIN;
VIRUS VECTOR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AFRICA;
CLINICAL RESEARCH;
DRUG INDUSTRY;
DRUG RESEARCH;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NOTE;
PRIORITY JOURNAL;
TREATMENT FAILURE;
UNITED STATES;
VACCINATION;
AIDS VACCINES;
DRUG APPROVAL;
DRUG DESIGN;
DRUG INDUSTRY;
UNITED STATES;
|
|
EID: 44949125587
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0608-591 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|
